Investor Ideas Potcasts #Cannabis News and Stocks on the Move: (CSE: $AGRO.C) (TSX-V: $OGO.V) (OTC: $OGOFF) (CSE: $NTAR.C) (OTC: $NEXCF) (CSE: $FONE.C) (OTCQB: $FLOOF) (TSX: $TRST.TO)
Delta, Kelowna, BC - January 22, 2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today's edition of Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Investor Ideas Potcasts #Cannabis News and Stocks on the Move: (CSE: $AGRO.C) (TSX-V: $OGO.V) (OTC: $OGOFF), (CSE: $NTAR.C) (OTC: $NEXCF), (CSE: $FONE.C) (OTCQB: $FLOOF) (TSX: $TRST.TO)
Hear Investor ideas cannabis potcast on iTunes
Today's podcast overview/transcript:
Good afternoon and welcome to another Investorideas.com "potcast", looking at cannabis news, stocks to watch as well as insights from thought leaders and experts.
Today we will be looking at announcements from Agrios Global Holdings Ltd. (CSE: AGRO), Organto Foods Inc. (TSX-V: OGO) (OTC: OGOFF), Cannvas MedTech Inc. (CSE: MTEC) (OTCPK: CANVF), NexTech AR Solutions Corp.(CSE: NTAR) (OTC: NEXCF), Flower One Holdings Inc. (CSE: FONE) (OTCQB: FLOOF) and CannTrust Holdings Inc. (TSX: TRST).
But first, Medicinal Genomics Corporation, a pioneer in using genomics to improve the transparency, safety and yield of cannabis has today announced the industry's most comprehensive Cannabis reference genome, a high quality de novo genome assembly of the Jamaican Lion cannabis strain. As the first reference genome to break the "usability barrier," the significance of this development cannot be overstated. Having a comprehensive cannabis genome opens the door to a host of industry innovations, including enabling cannabis research in states and countries where cannabis is still illegal, marker-assisted selection (MAS) for genetically-based strain identification, accelerated breeding to improve production yields, reliable seed-to-sale tracking systems, and pathogen identification to ensure cannabis purity and safety.
"For the first time, growers and breeders will have a complete and reliable genome from which to create new strains for increased yields and productivity, while documenting them to protect their work. Cultivators will also be able to embark on a brand new era of intelligent breeding destined to change the way cannabis is grown, sold and consumed," said Kevin McKernan, chief science officer for Medicinal Genomics. "And this is just the beginning of enhancing cannabis yield with genomics. This plant that has the potential to be more valuable than wheat and corn combined, but with far more varied and diverse uses, including everything from CO2 sequestration to pain relief and medical therapies to complete vegetable proteins, clothing and industrial materials."
MGC was the first to sequence the cannabis genome with its sequencing of the Chemdawg cultivar in 2011. Since then, major breakthroughs in sequencing technology have enabled their reference of the cannabis genome to greatly exceed the standards set by the Human Genome Project in 2001. The company has also steadily applied these improvements by adding more genomes to its Kannapedia knowledge database, and in 2018, in validation of the company's progress their work was underwritten by the DASH Cryptocurrency.
Agrios Global Holdings Ltd. announced it will be establishing a subsidiary business unit in the State of Missouri to provide consulting services related to the regulatory changes that come into affect with the state's recent approval of medical cannabis. The Company's initial focus is preparing license applications for qualified clients who wish to enter the emerging medical cannabis business in Missouri.
Agrios Global Holdings has been assessing the opportunity for expansion into Missouri pending the outcome of a proposed constitutional amendment, the Medical Marijuana and Veteran Healthcare Services Initiative, which was approved on November 6, 2018. The measure has legalized marijuana use for medical purposes under state law, but does not change federal law, which still makes marijuana possession, sale and cultivation a federal offense.
Agrios Global Holdings' Director, Larry Ellison, a long-time advocate of the recent changes to the Missouri marijuana legislation, commented, "Potential cultivation, manufacturing and dispensary license applicants will require the guidance of someone with a clear understanding of the regulatory environment under which marijuana can be cultivated in Missouri. Agrios will offer services to assist clients with license applications and can offer those who obtain licenses further advisory and consulting services in areas such as dispensary operations, agriculture technology and agronomy services for improving crop quality."
Organto Foods Inc. today announced that the Organto Global Cannabis Group, through its wholly-owned subsidiary, Medicannabis S.A.S. has filed registrations for a total of 144 cultivars (i.e., strains) and breeding lines as Fuente Semillera (translated, "Source Seed") with the Instituto Colombiano Agropecuario (ICA), Colombia's agricultural authority.
All cannabis plants grown in Colombia must be derived from registered Fuente Semillera in order to be permitted for use. Licensed cannabis producers had until December 31, 2018 to file these registrations. Medicannabis filed technical sheets for 144 cultivars and breeding lines in advance of the deadline thereby establishing a large and diverse genetic library for the company to cross-breed and develop numerous new cultivars with a wide variety of trait combinations (flavor, aroma, medicinal properties, phytochemistry, etc.).
"A large and broadly diverse genetic library is the foundation for a successful plant breeding program, key for the development of commercially successful varieties and product applications." commented Todd Dalotto, President of the Organto Global Cannabis Group. "Our Fuente Semillera library will allow us to create new cultivars with seemingly infinite combinations of traits that include phytochemistry (i.e., high/low-THC, high-CBD, THCV, CBG, and terpenes), mold-resistance, aromas, flavors, and suitability to various climates and growing environments."
Cannvas MedTech Inc., a leading digital cannabis educator and business technology company, announced it has agreed to a deal with NexTech AR Solutions Corp., whose mission is to bring augmented reality (AR) to the masses through its web-enabled AR e-commerce, AR e-learning and AR live streaming platforms to create the first AR ecosystem, to collaborate on enhancing the user experience of its digital cannabis education kiosks across Canada.
"Working with NexTech allows Cannvas the opportunity to create a first-to-market AR-based cannabis learning program and lead the way for the digital evolution of education as it continues to intertwine with technology to generate new and exciting ways for people to take in information," said Steve Loutskou, Chief Operating Officer, Global Markets, Cannvas MedTech Inc. "It has been proven that companies who personalize the user experience through AR enjoy an improvement in their customer relations and overall profitability, and our goal through this partnership with NexTech is to take our Cannvas Kiosk to the next level and ensure users receive accurate and evidence-based cannabis information customized to their needs and location."
NexTech brings AR to a wide audience through its own AR ecosystem, featuring e-commerce solutions for websites, AR learning and education and AR live streaming for events. Its AR web-enabled e-commerce platform is currently integrated with Shopify, WordPress and Magento, and its e-learning platform "edCetra" has been used by Fortune 500 companies such as Imperial Oil, Bombardier and Staples, as well as the Library of Congress and others to educate and train employees.
Flower One Holdings Inc. today announced a new licensing agreement and Brand Partnership for cannabis-product fulfillment in Nevada with California-based, Old Pal, the popular lifestyle cannabis brand that offers the most affordable legal cannabis in the state of California. Flower One is now licensed to produce, manufacture and distribute the entire Old Pal product line to Nevada's 130 cannabis retailers, marking Old Pal's first out-of-state expansion and entry into the Nevada market.
"Flower One is thrilled to bring a California favorite, Old Pal, to the Nevada market to ensure that our retail partners and, subsequently, consumers have access to quality, affordable and abundant cannabis flower," says Ken Villazor, President and CEO of Flower One. "As Flower One continues to secure more Brand Partners for the Nevada market, we remain focused on meeting the needs of all levels of the value chain, ranging from affordable 'shareable flower,' like Old Pal's suite of products, to high-end luxury products."
Rusty Wilenkin, Co-Founder & CEO of Old Pal has had his sights set on a Nevada expansion since his California sales started to soar, "California has already taken off and we're positive that our second market will see even more success. The opportunity in Nevada is huge, with 55 million tourists landing in Nevada every year we really have the chance to showcase our brand on an international stage."
CannTrust Holdings Inc., one of Canada's leading, most trusted licensed producers of cannabis and the 2018 Canadian Cannabis Awards "Top Licensed Producer of the Year", announced it has obtained the necessary permitting from the Town of Pelham to proceed with its Phase III expansion with the construction process set to commence immediately.
The revised Phase III expansion is permitted for a footprint of up to 390,000 square feet, compared to the 600,000 square feet in the Company's initial application. However, with enhancements to the Phase III facility above and beyond the specifications initially contemplated, CannTrust maintains its total production capacity forecast of 100,000 kg per year after completion of the Phase III construction.
The enhancements to the Phase III expansion include investing in automation and a higher level of climate control. Given these enhancements and the time it has taken to obtain permitting, construction of the Phase III expansion is expected to be complete in the third quarter of 2020. Initial harvest from the Phase III expansion is expected in the second quarter of 2020 and full production capacity is expected in the second half of 2020. In order to address local concerns from the emission of light from its facilities, CannTrust is proceeding to add additional fan ventilation so its shades can be completely closed, at minimal incremental cost.
Subscribe to the new cannabis podcast series:
To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
Get the cannabis/hemp stock directory as an Investor ideas member , plus get weekly updates with new pot stocks added and get the daily potcast for Investor Ideas #Potcasts #Cannabis News and Stocks on the Move. Learn more https://www.investorideas.com/membership/
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and sector trends from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto, technology including AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts#Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change Podcast and the AI Eye Podcast and column covering developments in AI.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers.
Learn more about Investor ideas podcast and news publication services and costs https://www.investorideas.com/News-Upload/
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: https://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.
Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment
Follow us on Social Media
Contact Investorideas.com
800-665-0411
No comments:
Post a Comment